UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up

American journal of hematology, 2014-07, Vol.89 (7), p.732-742

2014

Volltextzugriff (PDF)

Expanding Nilotinib Access in Clinical Trials (ENACT): An Open-Label, Multicenter Study of Oral Nilotinib in Adult Patients With Imatinib-Resistant or Imatinib-Intolerant Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in the Chronic Phase

Cancer, 2012, Vol.118 (1), p.118-126

2012

Volltextzugriff (PDF)

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

Proceedings of the National Academy of Sciences - PNAS, 2004-04, Vol.101 (15), p.5328-5335

2004

Volltextzugriff (PDF)

Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial

Blood, 2010-10, Vol.116 (14), p.2448-2454

2010

Volltextzugriff (PDF)

AML1-ETO and C-KIT Mutation/Overexpression in t(8;21) Leukemia: Implication in Stepwise Leukemogenesis and Response to Gleevec

Proceedings of the National Academy of Sciences - PNAS, 2005-01, Vol.102 (4), p.1104-1109

2005

Volltextzugriff (PDF)

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Blood, 2011-10, Vol.118 (17), p.4567-4576

2011

Volltextzugriff (PDF)

Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer

World journal of gastroenterology : WJG, 2005-02, Vol.11 (8), p.1210

2005

Volltextzugriff (PDF)

Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide

EBioMedicine, 2015-06, Vol.2 (6), p.563-571

2015

Volltextzugriff (PDF)

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Blood, 2015-04, Vol.125 (18), p.2771-2778

2015

Volltextzugriff (PDF)

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) : II. Clinical efficacy and pharmacokinetics in relapsed patients

Blood, 1997-05, Vol.89 (9), p.3354-3360

1997

Volltextzugriff (PDF)

Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia

British journal of clinical pharmacology, 2008-06, Vol.65 (6), p.885-892

2008

Volltextzugriff (PDF)

Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma： an open-label,observational, multi-center study in China

Chinese medical journal, 2011-10, Vol.124 (19), p.2969-2974

2011

Volltextzugriff (PDF)

Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies： an open-lable, multicenter, observational trial in a Chinese cohort

Chinese medical journal, 2011-11, Vol.124 (22), p.3670-3675

2011

Volltextzugriff (PDF)

Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor

Leukemia research, 2013-10, Vol.37 (10), p.1216-1221

2013

Volltextzugriff (PDF)

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma

Journal of hematology and oncology, 2010-09, Vol.3 (1), p.30-30, Article 30

2010

Volltextzugriff (PDF)

Trend in the incidence and geographic variations of acute lymphoblastic leukemia in Shanghai, China from 2002 to 2006

Chinese medical journal, 2011-08, Vol.124 (16), p.2406-2410

2011

Volltextzugriff (PDF)

Relationship between preoperative staging by endoscopic ultrasonography and MMP-9 expression in gastric carcinoma

World journal of gastroenterology : WJG, 2007-04, Vol.13 (14), p.2108

2007

Volltextzugriff (PDF)

Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study

Haematologica (Roma), 2013-07, Vol.98 (7), p.1045-1048

2013

Volltextzugriff (PDF)

Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006

Journal of experimental & clinical cancer research, 2010-03, Vol.29 (1), p.20-20, Article 20

2010

Volltextzugriff (PDF)

An epidemiological investigation of leukemia incidence between 2003 and 2007 in Nanjing, China

Journal of hematology and oncology, 2010-06, Vol.3 (1), p.21-21, Article 21

2010

Volltextzugriff (PDF)

A multi-center open-labeled study of recombinant erythropoietin-β in the treatment of anemic patients with multiple myeloma, low-grade non-Hodgkin’s lymphoma, or chronic lymphocytic leukemia in Chinese population

International journal of hematology, 2008-09, Vol.88 (2), p.139-144

2008

Volltextzugriff (PDF)

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients

Medical oncology (Northwood, London, England), 2012-09, Vol.29 (3), p.2176-2182

2012

Volltextzugriff (PDF)

Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study

International journal of clinical pharmacology and therapeutics, 2013-09, Vol.51 (9), p.738-745

2013

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(80)

Sprache

Englisch
(49)
Chinesisch
(32)

Erscheinungsjahr

n.n

Thema

Humans
(80)
Male
(77)
Female
(76)
Adult
(68)
Aged
(56)
Science & Technology
(42)
Adolescent
(40)
Life Sciences & Biomedicine
(40)
Treatment Outcome
(31)
Young Adult
(29)
Aged, 80 And Over
(20)
Prognosis
(19)
Hematology
(16)
Antineoplastic Agents - Therapeutic Use
(15)
Retrospective Studies
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Imatinib Mesylate
(12)
Oncology
(12)
General & Internal Medicine
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia

Expanding Nilotinib Access in Clinical Trials (ENACT): An Open-Label, Multicenter Study of Oral Nilotinib in Adult Patients With Imatinib-Resistant or Imatinib-Intolerant Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in the Chronic Phase

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial

AML1-ETO and C-KIT Mutation/Overexpression in t(8;21) Leukemia: Implication in Stepwise Leukemogenesis and Response to Gleevec

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial

Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer

Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide

Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL) : II. Clinical efficacy and pharmacokinetics in relapsed patients

Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia

Different dose combinations of bortezomib and dexamethasone in the treatment of relapsed or refractory myeloma： an open-label,observational, multi-center study in China

Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies： an open-lable, multicenter, observational trial in a Chinese cohort

Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma

Trend in the incidence and geographic variations of acute lymphoblastic leukemia in Shanghai, China from 2002 to 2006

Relationship between preoperative staging by endoscopic ultrasonography and MMP-9 expression in gastric carcinoma

Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study

Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006

An epidemiological investigation of leukemia incidence between 2003 and 2007 in Nanjing, China

A multi-center open-labeled study of recombinant erythropoietin-β in the treatment of anemic patients with multiple myeloma, low-grade non-Hodgkin’s lymphoma, or chronic lymphocytic leukemia in Chinese population

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients

Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study

Aktive Filter

Suchergebnisse filtern